California · 20252026

SB 1023

Health care coverage: antiretroviral drugs, drug devices, and drug products.

Bill record: Open States bulk CSV (bills/votes) ocd-bill/31bd219a-a31a-406b-83be-683faba102b0 CC0-1.0

Issue tags AI-classified

Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)

Sponsors + 1 cosponsors

Roll-call votes on this bill

Motion / questionChamberStageRollOutcomeYeaNayOtherDateSource
Do pass and be re-referred to the Committee on [Appropriations] lower 50473dd9-d0a7-4c2a-b4ee-88efbcf8e66a pass 11 0 5 Jun 9, 2026 Open States bulk CSV (bills/votes) ocd-vote/50473dd9-d0a7-4c2a-b4ee-88efbcf8e66a CC0-1.0
3rd Reading SB1023 Laird et al. upper 82a9639c-5467-4e9f-ac7b-aa939d7ddccb pass 29 0 11 May 18, 2026 Open States bulk CSV (bills/votes) ocd-vote/82a9639c-5467-4e9f-ac7b-aa939d7ddccb CC0-1.0
Do pass upper 325bf1d6-656e-4c52-b4ab-d65acea859db pass 5 0 2 May 14, 2026 Open States bulk CSV (bills/votes) ocd-vote/325bf1d6-656e-4c52-b4ab-d65acea859db CC0-1.0
Placed on suspense file upper e91f91b3-cb47-4f7e-a3fe-ec85886c261e pass 7 0 0 Apr 20, 2026 Open States bulk CSV (bills/votes) ocd-vote/e91f91b3-cb47-4f7e-a3fe-ec85886c261e CC0-1.0
Do pass, but first be re-referred to the Committee on [Appropriations] upper 6e9a891e-c939-4e91-8f17-6ed8fe75784a pass 9 0 2 Apr 8, 2026 Open States bulk CSV (bills/votes) ocd-vote/6e9a891e-c939-4e91-8f17-6ed8fe75784a CC0-1.0